Growth hormone/insulin‐like growth factor 1 dynamics in adult living donor liver transplantation
Maximilian Jara, Antje Schulz, Maciej Malinowski, Gero Puhl, Johan Friso Lock, Daniel Seehofer, Peter Neuhaus, Martin Stockmann – 30 May 2014 – End‐stage liver disease is accompanied by decreased serum levels of insulin‐like growth factor 1 (IGF1) and inversely increased serum levels of growth hormone (GH). Previous reports have demonstrated rapid GH/IGF1 axis recovery after orthotopic liver transplantation.